Current Issues in International Entrepreneurship
Show Less

Current Issues in International Entrepreneurship

Edited by Hamid Etemad, Tage Koed Madsen, Erik S. Rasmussen and Per Servais

The young field of international entrepreneurship is rapidly expanding in scope and complexity, as increasingly more companies across the world compete to gain a larger global market share and attract consumers both at home and abroad. This book, the fifth volume in the McGill International Entrepreneurship series, brings together 29 scholars and practitioners to explore the contemporary issues, evolving relations and dynamic forces that are shaping the new emerging entrepreneurial system in international markets. It examines entrepreneurial efforts and relations in many firms embedded in and constrained by different national and corporate cultures of their own and offers expert recommendations for further research, better managerial practice and more effective public policy approaches.
Buy Book in Print
Show Summary Details
You do not have access to this content

Chapter 4: The process of commercializing a medical technology innovation for an INV through international trade fairs: combining a network with a practice view

Hélène Laurell


The use of trade fairs as a meeting place is an old and established venue for business exchanges, and this chapter studies how an international new venture (INV) uses international trade fairs as one area to commercialize a medical technology innovation on the international market. Some industries would be regarded as more global and knowledge-intensive than others, for example the life science industry which includes fields such as pharmaceuticals, biotechnology and medical technology. Therefore this means that the needs for new medical technology products often tend to be global, but just as there are many countries in the world, there are also many differences between how these individual countries adopt innovations. Developing or creating a new market in an unstable environment almost always involves a high degree of uncertainty and can take a long time. Most markets take 15 years to coalesce, and one example is the internet (Sarasvathy and Dew 2005). As a result the failure rate among new ventures can be high, and the time before actual sales are generated for new medical technology innovations can be substantial. Keeping this in mind it becomes important to understand how and why a firm interacts with different actors in order to commercialize these innovations.

You are not authenticated to view the full text of this chapter or article.

Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.

Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.

Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.

Further information

or login to access all content.